Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
BioProcess Internation...BioProcess International US West
Not Confirmed
Not Confirmed
09-11 March, 2026
BioProcess Internation...BioProcess International
Not Confirmed
Not Confirmed
09-11 March, 2026
Not Confirmed
Not Confirmed
09-11 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
BioProcess Internation...BioProcess International US West
Industry Trade Show
Not Confirmed
09-11 March, 2026
BioProcess Internation...BioProcess International
Industry Trade Show
Not Confirmed
09-11 March, 2026
Industry Trade Show
Not Confirmed
09-11 March, 2026
Digital content

05 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/05/3249959/0/en/ITM-Announces-Phase-3-COMPETE-Trial-Post-Hoc-Subgroup-Analyses-with-n-c-a-Lu-edotreotide-ITM-11-in-Patients-with-Pancreatic-Neuroendocrine-Tumors-at-ENETS-2026-Conference.html

25 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/25/3244531/0/en/ITM-to-Announce-Phase-3-COMPETE-Trial-Post-Hoc-Subgroup-Analysis-in-Pancreatic-Neuroendocrine-Tumors-and-Host-Satellite-Symposium-at-ENETS-2026.html

11 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/11/3203708/0/en/ITM-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

17 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/17/3188899/0/en/ITM-Receives-U-S-FDA-Fast-Track-Designation-for-ITM-94-as-a-Diagnostic-Agent-for-Clear-Cell-Renal-Cell-Carcinoma.html

13 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/13/3187074/0/en/ITM-Announces-FDA-Acceptance-of-New-Drug-Application-NDA-and-PDUFA-Date-for-n-c-a-177Lu-edotreotide-ITM-11-in-Gastroenteropancreatic-Neuroendocrine-Tumors-GEP-NETs.html

25 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/25/3174139/0/en/ITM-Announces-Analyses-from-Phase-3-COMPETE-Data-Showing-Higher-Objective-Response-Rates-with-n-c-a-177Lu-edotreotide-ITM-11-vs-Everolimus-Across-Subgroups-of-Patients-with-GEP-NET.html
ABOUT THIS PAGE
Isotope Technologies Munich is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Lutetium-177 bulk with DMF offered by Isotope Technologies Munich
Find a price of Gallium bulk offered by Isotope Technologies Munich